| Cardiovascular disease prevention: lipid lowering therapy for people newly diagnosed with hypertension or T2DM | IND287 | | |
| Cardiovascular disease prevention: cholesterol treatment target (secondary prevention) | IND278 | | |
| Diabetes: lipid-lowering therapies for primary prevention of CVD (T2DM and 10% risk) | IND274 | | |
| Diabetes: T1DM and lipid-lowering therapies | IND277 | | |
| Asthma: annual review | IND273 | | |
| Diabetes: lipid-lowering therapies for secondary prevention of CVD | IND276 | | |
| Asthma: objective tests | IND272 | | |
| Diabetes: lipid-lowering therapies for primary prevention of CVD (40 years and over) | IND275 | | |
| Mortality: life expectancy at 75 | IND279 | | |
| Cancer: breast screening (53 to 70 years) | IND65 | | |
| Cancer: breast cancer mortality rate | IND4 | | |
| Cardiovascular disease prevention: risk assessment (general population) | IND269 | | |
| Smoking: cessation success in people with bipolar, schizophrenia and other psychoses | IND271 | | |
| Cardiovascular disease prevention: risk assessment (modifiable risk factors) | IND270 | | |
| Embolism and thrombosis: mortality rates from VTE | IND61 | | |
| Pregnancy and neonates: mental health at booking appointment | IND63 | | |
| Gynaecological conditions: rates of hysterectomy (heavy menstrual bleeding) | IND58 | | |
| Gynaecological conditions: rates of endometrial ablation (heavy menstrual bleeding) | IND59 | | |
| Dementia: anti-psychotic prescriptions | IND12 | | |
| Experience: A&E | IND291 | | |
| Experience: Maternity | IND292 | | |
| Experience: hospital | IND290 | | |
| Experience: Dental services | IND289 | | |
| Experience: GP services | IND288 | | |
| Healthcare-associated infections: incidence of Clostridium difficile (C. diff) | IND286 | | |